MedPath

Clinical trial on comparing the effect of vaginal Shallomine containing the pure fraction of shallot extract and clotrimazole in treatment of candidal vaginitis

Phase 2
Conditions
Condition 1: Candidiasis. Condition 2: Candidiasis of vulva and vagin.
Candidiasis
Candidiasis of vulva and vagina
B37.3
Registration Number
IRCT20190728044356N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

aged between 18 and 50 years
Be married
Have 1 spouse
Have consent to participate in the study
Not allergic to herbal medicines
Not allergic to clotrimazole
Be literate

Exclusion Criteria

They have been taken antibiotics and corticosteroids for the past two weeks, according to the participant
Have any sores or lumps in the cervix based on observation with speculum
Present use of other herbal medicines
Have abnormal uterine bleeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of people with candidal vaginitis. Timepoint: Examination of Candida in the patient's vaginal discharge before the intervention and one week after taking the drug. Method of measurement: culture and Laboratory diagnosis of Candida.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath